Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1984 Sep;83(1):69-73.
doi: 10.1111/j.1476-5381.1984.tb10120.x.

Biphasic effect of methylxanthines on acetylcholine release from electrically-stimulated brain slices

Biphasic effect of methylxanthines on acetylcholine release from electrically-stimulated brain slices

F Pedata et al. Br J Pharmacol. 1984 Sep.

Abstract

The effect of caffeine and aminophylline on the release of acetylcholine (ACh) was investigated in slices of rat cortex perfused with Krebs solution at rest and during electrical stimulation at frequencies of 0.2, 1 and 5 Hz. Both methylxanthines added to the superfusing Krebs solution at a concentration of 50 microM enhanced ACh release. Conversely, at a concentration of 0.5 mM both caffeine and aminophylline decreased ACh release. Neither caffeine nor aminophylline affected the unstimulated ACh release. Dipyridamole 10 microM potentiated the inhibitory effect of adenosine 30 microM on ACh release and antagonized both the stimulatory and inhibitory effects of caffeine on ACh release. The inhibitory effect of caffeine was antagonized by cyclohexyladenosine (CHA) 0.5 microM and N-ethylcarboxamideadenosine (NECA) 5 microM. The results indicate that methylxanthines exert both stimulatory and inhibitory effects on ACh release by acting on adenosine receptors. Methylxanthines may enhance the electrically-evoked ACh release by antagonizing the effect of endogenous adenosine on inhibitory adenosine receptors. On the other hand the mechanism through which methylxanthines decrease ACh release remains obscure.

PubMed Disclaimer

References

    1. J Pharmacol Exp Ther. 1965 Oct;150(1):146-51 - PubMed
    1. J Gen Physiol. 1967 Sep;50(8):2109-28 - PubMed
    1. J Pharmacol Exp Ther. 1969 Oct;169(2):308-14 - PubMed
    1. Eur J Pharmacol. 1970 Apr;10(1):64-71 - PubMed
    1. Neuroscience. 1976;1(5):391-8 - PubMed

Publication types

LinkOut - more resources